This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedron, T.
Right arrow Articles by Chaby, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedron, T.
Right arrow Articles by Chaby, R.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, November 1999, p. 885-890, Vol. 6, No. 6
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Exogenous Cyclic AMP, Cholera Toxin, and Endotoxin Induce Expression of the Lipopolysaccharide Receptor CD14 in Murine Bone Marrow Cells: Role of Purinoreceptors

Thierry Pedron,1 Robert Girard,1 and Richard Chaby2,*

Molecular Immunophysiology Unit, URA-1961, National Center for Scientific Research, Pasteur Institute, Paris,1 and Endotoxin Group, UMR-8619, National Center for Scientific Research, University of Paris-Sud, Orsay,2 France

Received 26 April 1999/Returned for modification 29 July 1999/Accepted 14 September 1999

Little is known about the mechanisms of lipopolysaccharide (LPS) signaling in immature cells that do not express the LPS receptor CD14 yet. Bone marrow granulocytes do not constitutively express CD14 but can be stimulated by low doses of LPS in the absence of serum and then express an inducible form of LPS receptor (iLpsR). We show that in addition to LPS, cholera toxin (CT) and various cyclic AMP (cAMP) analogs can also induce the expression of iLpsR, which was identified as CD14. Induction was independent of intracellular cAMP. The hypothesis that cAMP analogs act via a cell surface receptor was suggested by the unresponsiveness of trypsin-treated cells to these inducers and by the specific binding of [3H]cAMP to the cells. This binding was not inhibited by LPS or CT but was inhibited by various purine derivatives. However, the receptor involved is not a conventional purinoreceptor since both an agonist and an antagonist of such receptors were able to induce iLpsR expression. The results suggest that cAMP analogs and other purine derivatives induce iLpsR after interaction with an unconventional, trypsin-sensitive, purinoreceptor distinct from LPS and CT receptors.


* Corresponding author. Mailing address: Equipe "Endotoxines," UMR-8619 du CNRS, Bâtiment 430, Université de Paris-Sud, 91405 Orsay Cedex, France. Phone: 33-169154830. Fax: 33-169853715. E-mail: richard.chaby{at}bbmpc.u-psud.fr.


Clinical and Diagnostic Laboratory Immunology, November 1999, p. 885-890, Vol. 6, No. 6
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Pedron, T., Girard, R., Chaby, R. (2003). TLR4-dependent Lipopolysaccharide-induced Shedding of Tumor Necrosis Factor Receptors in Mouse Bone Marrow Granulocytes. J. Biol. Chem. 278: 20555-20564 [Abstract] [Full Text]  
  • Bankir, L., Ahloulay, M., Devreotes, P. N., Parent, C. A. (2002). Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved?. Am. J. Physiol. Renal Physiol. 282: F376-F392 [Abstract] [Full Text]